摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-tosyl-L-prolyl chloride

中文名称
——
中文别名
——
英文名称
N-tosyl-L-prolyl chloride
英文别名
N-tosyl-(S)-prolyl chloride;(2S)-1-(4-methylphenyl)sulfonylpyrrolidine-2-carbonyl chloride
N-tosyl-L-prolyl chloride化学式
CAS
——
化学式
C12H14ClNO3S
mdl
——
分子量
287.767
InChiKey
LXXUQMYYLZNIFI-NSHDSACASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    62.8
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Preparation of both enantiomers of 1-allyl-1,2,3,4-tetrahydro-β-carboline using allyltin reagents and a chiral auxiliary derived from l-proline
    摘要:
    beta -Carboline, which had an acyl group derived from L-proline at the 9-position, reacted with allyltributyltin and 2,2,2-trichloroethyl chloroformate, to afford an 1-allyl-1,2-dihydro-beta -carboline derivative in a diastereo selective manner. The chiral acyl group at N-9 was readily eliminated by aqueous alkali to give a corresponding carboxylic acid. The formed 1-allyl-1,2-dihydro-beta -carboline was transformed via two reduction steps to 1-alkyl-1,2,3,4-tetrahydro-beta -carboline in high ee. When the allylation was carried out using tetraallyltin instead of allyltributyltin, the stereoselectivity was reversed, and the antipode of the allyl adduct was obtained in high yield and ee in the presence of tin(IV) tetraiodide. Thus, it was found that both enantiomers of 1-allyl-beta -carboline were obtained in good enantioselectivities by the use of the same chiral auxiliary. (C) 2001 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0040-4020(01)00684-6
  • 作为产物:
    描述:
    1-(甲苯-4-磺酰基)-吡咯烷-2-羧酸氯化亚砜 作用下, 以 为溶剂, 反应 5.0h, 生成 N-tosyl-L-prolyl chloride
    参考文献:
    名称:
    7- [3-(1-氨基烷基)吡咯烷基]-和7- [3-1-氨基环烷基]吡咯烷基]-喹诺酮抗菌剂的合成及构效关系。
    摘要:
    已经制备了一系列的7- [3-(1-氨基烷基和1-氨基环烷基)-1-吡咯烷基]喹诺酮并评估了它们的生物学特性。其中,1-(S)-氨基烷基衍生物对革兰氏阳性和革兰氏阴性生物显示出有效的抗菌活性。与氨基甲基同类物相比,它们具有中等的亲脂性和较高的水溶性。例如,3-(1-氨基乙基)-1-吡咯烷基化合物(83)的药代动力学特性优于其氨基甲基对应物(6)。
    DOI:
    10.1248/cpb.42.1442
点击查看最新优质反应信息

文献信息

  • Synthesis of enantiomers of 3-methyl- and 3-phenyl-3,4-dihydro-2H-[1,4]benzothiazines and their 1,1-dioxides via an acylative kinetic resolution protocol
    作者:Dmitry A. Gruzdev、Evgeny N. Chulakov、Liliya Sh. Sadretdinova、Mikhail I. Kodess、Galina L. Levit、Victor P. Krasnov
    DOI:10.1016/j.tetasy.2015.01.010
    日期:2015.2
    (ee >97%). This method proved to be less suitable for the preparation of the (S)-enantiomer of 3,4-dihydro-3-phenyl-2H-[1,4]benzothiazine (ee up to 93%) and its sulfone (ee 82%) which were both obtained in low yields. The loss of enantioselectivity for (S)-3,4-dihydro-3-phenyl-2H-[1,4]benzothiazine and its sulfone occurred during hydrolysis of the corresponding diastereoisomerically pure amides.
    已经发现,(的酰氯小号) -萘普生,Ñ -phthaloyl-(小号) -亮氨酸,和Ñ甲苯磺酰基(小号) -脯氨酸是外消旋的3-甲基的acylative动力学拆分高效手性拆分试剂和3-苯基-3,4-二氢-3-甲基-2 ħ - [1,4]苯并噻嗪。基于该实验结果,包括acylative动力学拆分制备性协议,随后通过单个(主)非对映体酰胺和酰胺键的随后水解分离,提出了。使用与各种手性拆分剂该方法中,(小号) -和(- [R)3,4-二氢-3-甲基-2 -对映体ħ-得到[1,4]苯并噻嗪(EE> 99%)。酰胺的非对映体相应的氧化,随后导致了(脱酰小号) -和(- [R )-对映体的3,4-二氢-3-甲基-2 ħ - [1,4]苯并噻嗪1,1-二氧化钛(ee值> 97%)。这种方法被证明是不适合的(制备小号)3,4-二氢-3-苯基-2 -对映体ħ - [1,4]苯并噻嗪(EE高达93%)和它的砜(EE
  • Newly designed acylsilanes as versatile tools in organic synthesis
    作者:Bianca F Bonini、Mauro Comes-Franchini、Mariafrancesca Fochi、Germana Mazzanti、Alfredo Ricci
    DOI:10.1016/s0022-328x(98)00694-9
    日期:1998.9
    Structural variations in acylsilane molecules allow a number of new selective synthetic processes to be performed which lead to sulfur-containing heterocycles, highly functionalized and unsaturated polycarbonyl derivatives, polyenes, and β- and γ-aminoalcohols. The synthesis of these compounds, most of them not easily accessible through conventional routes, takes advantage of the site-selective reactions
    酰基硅烷分子的结构变化允许执行许多新的选择性合成工艺,这些工艺会导致含硫杂环,高度官能化和不饱和的多羰基衍生物,多烯以及β-和γ-氨基醇。这些化合物的合成(大多数都不易通过常规途径获得)利用C-Si键处发生的位点选择反应,相对于相应醛而言,酰基硅烷的稳定性提高以及SiR 3引入的非对面选择性团体。在本文中,我们报告了导致几种功能化酰基硅烷的合成及其合成应用的不同合成策略。还将介绍使用新的选择性多金属试剂进行亲核甲硅烷基化的方法。
  • Conformationally Constrained Dipeptide Surrogates with Aromatic Side-Chains:  Synthesis of 4-Aryl Indolizidin-9-one Amino Acids by Conjugate Addition to a Common α,ω-Diaminoazelate Enone Intermediate
    作者:Jérôme Cluzeau、William D. Lubell
    DOI:10.1021/jo0355855
    日期:2004.3.1
    Four methyl 9-oxo-8-(N-(Boc)-amino)-4-phenyl-1-azabicyclo[4.3.0]nonane carboxylates (11, 4-Ph-I9aa-OMe) were synthesized from (2S,8S,5E)-di-tert-butyl-4-oxo-5-ene-2,8-bis[N-(PhF)amino]azelate [(5E)-7, PhF = 9-(9-phenylfluorenyl)] via a seven-step process featuring a conjugate addition/reductive amination/lactam cyclization sequence. Various nucleophiles were used in the conjugate addition reactions
    四个甲基-9-氧代-8-(ñ - (BOC) -氨基)-4-苯基-1-氮杂双环[4.3.0]壬烷羧酸(11,4-PH-I 9 AA-OME)从(2合成S,8 S,5 E)-二叔丁基-4-氧代-5-烯-2,8-双[ N-(PhF)氨基]壬二酸酯[(5 E)-7,PhF = 9-( 9-苯基芴基)]通过共轭加成/还原胺化/内酰胺环化序列为特征的七步过程。烯酮(5 E)-7的共轭加成反应中使用了各种亲核试剂作为制备具有不同取代基的α,ω-二氨基壬二酸酯的一般途径,尽管非对映选择性低,但芳基格氏试剂(9/1至15/1 drs)除外。通过色谱法和非对映选择性沉淀分离6-苯基壬二酸酯(6 S)-8d和(6 R)-8d,并独立地转化成4-Ph-1 I 9 aa-OMe。由(6 S)-8d选择性地以51%的产率制备(2 S,4 R,6 R,8 S)-4-Ph-I 9 aa-OMe 11。(6还原胺化- [R
  • Synthesis, enantiomeric separation and docking studies of spiropiperidine analogues as ligands of the nociceptin/orphanin FQ receptor
    作者:Umberto M. Battisti、Sandra Corrado、Claudia Sorbi、Andrea Cornia、Annalisa Tait、Davide Malfacini、Maria Camilla Cerlesi、Girolamo Calò、Livio Brasili
    DOI:10.1039/c4md00082j
    日期:——
    A series of triazospirodecanone derivatives were synthesized as potential NOP ligands. 8-(Chroman-4-yl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (4) and its 5-fluoro analogue (18) proved to be active as agonists with EC50 values in the submicromolar range. Single enantiomers of compound 4 were separated and tested as NOP agonists; the eutomer R-(+)-4 showed a pEC50 of 7.34. Finally docking studies were performed on the NOP receptor to identify the most significant stereospecific interactions.
    一系列三氮杂螺癸烷-4-酮衍生物被合成作为潜在的NOP配体。8-(色满-4-基)-1-苯基-1,3,8-三氮杂螺[4.5]癸烷-4-酮(4)及其5-氟类似物(18)被证明是具有亚微摩尔级EC50值的激动剂。化合物4的单一旋光异构体被分离并测试为NOP激动剂;优旋体R-(+)-4显示出7.34的pEC50值。最后,对NOP受体进行了对接研究,以识别最重要的立体特异性相互作用。
  • Structure–Activity Relationship Studies with Tetrahydroquinoline Analogs as EPAC Inhibitors
    作者:Yogesh A. Sonawane、Yingmin Zhu、Jered C. Garrison、Edward L. Ezell、Muhammad Zahid、Xiaodong Cheng、Amarnath Natarajan
    DOI:10.1021/acsmedchemlett.7b00358
    日期:2017.11.9
    metastasis. Several laboratories use a tetrahydroquinoline analog, CE3F4, to dissect the role of EPAC1 in various disease states. Here, we report SAR studies with tetrahydroquinoline analogs that explore various functional groups. The most potent EPAC inhibitor 12a exists as a mixture of inseparable E (major) and Z (minor) rotamers. The rotation about the N-formyl group indeed impacts the activity against
    EPAC蛋白是潜在治疗心脏肥大和癌症转移的治疗靶标。一些实验室使用四氢喹啉类似物CE3F4来剖析EPAC1在各种疾病状态中的作用。在这里,我们报道了使用四氢喹啉类似物探索各种功能基团的SAR研究。最有效的EPAC抑制剂12a以不可分离的E(主要)和Z(次要)旋转异构体的混合物形式存在。围绕N-甲酰基的旋转确实影响了针对EPAC的活性。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐